Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 111301-111350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03170349
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
NA
Active, not recruiting
124 participants
Started: Jun 27, 2017 · Completed: Aug 31, 2025
1 condition
1 sponsor
17 locations
NCT03100149
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
PHASE2
Active, not recruiting
316 participants
Started: Jun 27, 2017 · Completed: Dec 1, 2031
1 condition
2 sponsors
56 locations
NCT03208374
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
N/A
Active, not recruiting
1,600 participants
Started: Jun 27, 2017 · Completed: Jun 30, 2026
2 conditions
1 sponsor
7 locations
NCT03198650
A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies
PHASE1
Active, not recruiting
35 participants
Started: Jun 27, 2017 · Completed: Dec 31, 2025
3 conditions
1 sponsor
14 locations
NCT02942615
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
NA
Active, not recruiting
220 participants
Started: Jun 27, 2017 · Completed: Oct 31, 2025
2 conditions
5 sponsors
1 location
NCT04586400
Chromosome 9 P Minus Syndrome
N/A
Recruiting
200 participants
Started: Jun 27, 2017 · Completed: Jun 30, 2026
5 conditions
5 sponsors
1 location
NCT03064867
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE1/PHASE2
Active, not recruiting
65 participants
Started: Jun 26, 2017 · Completed: Aug 12, 2023
1 condition
1 sponsor
3 locations
NCT03162536
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
PHASE1/PHASE2
Active, not recruiting
190 participants
Started: Jun 26, 2017 · Completed: Sep 18, 2026
9 conditions
1 sponsor
10 locations
NCT02835638
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV
N/A
Active, not recruiting
520 participants
Started: Jun 26, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
28 locations
NCT04471493
Pediatric and Ambulatory Research in Infectious Diseases
N/A
Recruiting
400,000 participants
Started: Jun 26, 2017 · Completed: Aug 2, 2030
7 conditions
6 sponsors
1 location
NCT03161353
Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.
PHASE2
Active, not recruiting
377 participants
Started: Jun 26, 2017 · Completed: Nov 1, 2026
1 condition
1 sponsor
56 locations
NCT03110978
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
140 participants
Started: Jun 26, 2017 · Completed: Jun 30, 2026
14 conditions
1 sponsor
3 locations
NCT03113643
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
PHASE1
Recruiting
72 participants
Started: Jun 26, 2017 · Completed: May 31, 2027
3 conditions
2 sponsors
3 locations
NCT03054584
Genetic Basis of Melanocytic Nevi
N/A
Recruiting
50 participants
Started: Jun 26, 2017 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT03204123
PSMA PET Imaging of Recurrent Prostate Cancer
PHASE2
Active, not recruiting
1,171 participants
Started: Jun 26, 2017 · Completed: Jun 30, 2026
2 conditions
1 sponsor
7 locations
NCT02840201
Sub-Clinical Atrial Fibrillation Biomarker Study
N/A
Active, not recruiting
700 participants
Started: Jun 26, 2017 · Completed: Dec 31, 2025
1 condition
7 sponsors
1 location
NCT03173248
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
PHASE3
Active, not recruiting
146 participants
Started: Jun 26, 2017 · Completed: Jun 30, 2026
4 conditions
1 sponsor
90 locations
NCT03165734
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
PHASE3
Recruiting
399 participants
Started: Jun 26, 2017 · Completed: Jul 30, 2027
3 conditions
2 sponsors
207 locations
NCT05668338
MED-EL HEARING SOLUTIONS (MEHS): AN OBSERVATIONAL STUDY
N/A
Recruiting
100 participants
Started: Jun 26, 2017 · Completed: Dec 31, 2028
1 condition
1 sponsor
8 locations
NCT05677568
The CINCH-FMR Post-Market Registry: Percutaneous Repair in Functional Mitral Regurgitation
N/A
Enrolling by invitation
250 participants
Started: Jun 24, 2017 · Completed: Jun 30, 2030
2 conditions
1 sponsor
19 locations
NCT06628934
Wearable Gait Sensors
N/A
Active, not recruiting
600 participants
Started: Jun 23, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06680492
The Role of Nutrition in Muscle Function of Bariatric Surgery Patients
N/A
Recruiting
75 participants
Started: Jun 23, 2017 · Completed: Jan 31, 2026
5 conditions
2 sponsors
1 location
NCT02839707
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
PHASE2/PHASE3
Active, not recruiting
444 participants
Started: Jun 23, 2017 · Completed: Mar 31, 2026
19 conditions
2 sponsors
924 locations
NCT03178799
Randomized Fracture Liaison Services
N/A
Enrolling by invitation
400 participants
Started: Jun 23, 2017 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03036930
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
PHASE2
Active, not recruiting
52 participants
Started: Jun 23, 2017 · Completed: Mar 6, 2026
2 conditions
1 sponsor
6 locations
NCT03094312
Evaluation of the Risk of Cognitive Deficit After Surgery of Epilepsy by Dynamic Spectral Imaging (ISD) of the Cognitive Functions in Patients Explored in StereoElectroEncephaloGraphy (SEEG)
NA
Recruiting
50 participants
Started: Jun 23, 2017 · Completed: Jan 23, 2030
1 condition
1 sponsor
1 location
NCT03238690
LVAD Conditioning for Cardiac Recovery
NA
Recruiting
100 participants
Started: Jun 23, 2017 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT03226301
A Prospective, Multicenter, Phase-II Trial of Ibrutinib Plus Venetoclax in Patients With Creatinine Clearance >= 30 ml/Min Who Have Relapsed or Refractory Chronic Lymphocytic Leukemia (RR-CLL) With or Without TP53 Aberrations
PHASE2
Active, not recruiting
230 participants
Started: Jun 23, 2017 · Completed: Jun 21, 2026
2 conditions
2 sponsors
49 locations
NCT03511534
Open/Aftercare Treatment for Participants Diagnosed With Obsessive Compulsive Disorder
NA
Active, not recruiting
200 participants
Started: Jun 23, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03307980
Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
PHASE2
Active, not recruiting
21 participants
Started: Jun 22, 2017 · Completed: Jun 8, 2029
1 condition
1 sponsor
22 locations
NCT03297775
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
N/A
Recruiting
750 participants
Started: Jun 22, 2017 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT02968810
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
PHASE2
Active, not recruiting
52 participants
Started: Jun 21, 2017 · Completed: Dec 23, 2025
2 conditions
1 sponsor
5 locations
NCT03096054
A CR-UK Phase I Trial of LY3143921
PHASE1
Active, not recruiting
69 participants
Started: Jun 21, 2017 · Completed: Feb 28, 2027
8 conditions
1 sponsor
4 locations
NCT03113344
Population Pharmacokinetics of Anti-infective Drugs in Children With Infectious Diseases
N/A
Recruiting
800 participants
Started: Jun 21, 2017 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT02947685
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
PHASE3
Active, not recruiting
518 participants
Started: Jun 21, 2017 · Completed: Jul 31, 2026
2 conditions
9 sponsors
106 locations
NCT04238871
RaDiCo PID Cohort (RaDiCo-ILD Cohort in English)
N/A
Recruiting
2,500 participants
Started: Jun 21, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
2 locations
NCT03169634
A Study Using Metaphyseal Cones Versus a Cemented Stem Construct in Revision TKR
NA
Active, not recruiting
61 participants
Started: Jun 21, 2017 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT03233139
Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies
PHASE1
Active, not recruiting
146 participants
Started: Jun 21, 2017 · Completed: Sep 30, 2027
1 condition
1 sponsor
20 locations
NCT03091257
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
PHASE1
Recruiting
30 participants
Started: Jun 21, 2017 · Completed: Sep 15, 2026
1 condition
4 sponsors
2 locations
NCT05815953
Polarstem Versus Corail; a Comparison of Micromotion and Periprosthetic Bone Remodelling of Two Femoral Stems
NA
Active, not recruiting
60 participants
Started: Jun 20, 2017 · Completed: Jan 31, 2033
1 condition
2 sponsors
1 location
NCT03147885
Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
43 participants
Started: Jun 20, 2017 · Completed: Dec 31, 2027
15 conditions
2 sponsors
1 location
NCT02949284
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
PHASE2
Active, not recruiting
90 participants
Started: Jun 20, 2017 · Completed: Nov 20, 2026
2 conditions
2 sponsors
2 locations
NCT03171012
Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke
NA
Recruiting
40 participants
Started: Jun 19, 2017 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT03250091
Surveillance of Patients With Precancerous Lesions of the Stomach
N/A
Recruiting
2,000 participants
Started: Jun 19, 2017 · Completed: Dec 31, 2027
4 conditions
4 sponsors
1 location
NCT04992871
Swiss Cerebral Palsy Registry
N/A
Recruiting
15,000 participants
Started: Jun 19, 2017 · Completed: Jan 31, 2071
1 condition
2 sponsors
8 locations
NCT02981628
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
PHASE2
Recruiting
80 participants
Started: Jun 19, 2017 · Completed: Mar 31, 2026
4 conditions
2 sponsors
156 locations
NCT03190278
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1
Active, not recruiting
29 participants
Started: Jun 19, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
8 locations
NCT02910531
Lipoic Acid Supplement for Cystine Stone
PHASE2
Active, not recruiting
50 participants
Started: Jun 19, 2017 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT03196466
Population Pharmacokinetics of Antiepileptic in Pediatrics
N/A
Recruiting
1,000 participants
Started: Jun 19, 2017 · Completed: Jun 19, 2026
1 condition
2 sponsors
1 location
NCT03224949
Comparison of ALD, NASH, and Healthy Control Patients
N/A
Recruiting
500 participants
Started: Jun 19, 2017 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
2224
2225
2226
2227
2228
2229
2230
More pages
2369
Next